Putnam Investments LLC Travere Therapeutics, Inc. Transaction History

Putnam Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$22.91 - $28.63 $20,733 - $25,910	-905 Reduced 1.79%	49,740 $1.23 Million
Q2 2022 Aug 15, 2022	SELL	$20.94 - $30.01 $13,108 - $18,786	-626 Reduced 1.22%	50,645 $1.23 Million
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $89,127 - $115,515	-3,775 Reduced 6.86%	51,271 $1.32 Million
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $1.34 Million - $1.72 Million	55,046 New	55,046 $1.71 Million

214

94.3M

1.2M

778K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.32B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.